Post-acute Infectious Syndrome - Aripiprazole Symptom Evaluation (PAIS-AriSE) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Post-acute Infectious Syndrome - Aripiprazole Symptom Evaluation (PAIS-AriSE)	COVID-19, Chronic Disease, Cognition Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Coronaviridae Infections, Disease Attributes, Fatigue, Hemic and Lymphatic Diseases, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, RNA Virus Infections, Signs and Symptoms, X-linked disease, blood coagulation disease, coagulation protein disease, cognitive disorder, hematologic disorder, hemophilia B, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder, long COVID-19, lung disorder, pneumonia, psychiatric disorder, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia	Not yet recruiting	Phase 2	2026-07-20		NCT07714213

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Christiana Franke	1

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Charité - Universitätsmedizin Berlin	Berlin	Germany	18